Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 9, 2011, Pages 1118-1126

  Aleman, Soo ^a   Endalib, Sanam ^a   Stäl, Per ^a   Lööf, Lars ^b   Lindgren, Stefan ^c   Sandberg Gertzén, Hanna ^d   Almer, Sven ^e   Olsson, Sigvard ^f   Danielsson, Åke ^g   Wallerstedt, Sven ^f   Hultcrantz, Rolf ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Centre for Clinical Research   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^e LINKÖPING UNIVERSITY   (Sweden)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arthralgia; Cirrhosis; Family screening; Health checks; Mortality

Indexed keywords

FERRITIN; TRANSFERRIN;

ADULT; ARTHRALGIA; ARTICLE; DISEASE SEVERITY; FAMILY ASSESSMENT; FAMILY SCREENING; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; GENETIC DISORDER; HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; HUMAN; IRON BLOOD LEVEL; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; SCREENING TEST; SURVIVAL RATE; SWEDEN; SYMPTOMATOLOGY;

ADULT; AGED; ARTHRALGIA; DNA MUTATIONAL ANALYSIS; EARLY DIAGNOSIS; FATIGUE; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHYSICAL EXAMINATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SWEDEN; TRANSFERRIN;

EID: 80051723867     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.591426     Document Type: Article

References (33)

1. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341: 718-24. (Pubitemid 29407371)
2. Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelønning K, Fjøsne U, et al. Screening for hemochro-matosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001; 36:1108-15. (Pubitemid 32801699)
3. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-78. (Pubitemid 40570925)
4. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13:399-408. (Pubitemid 26256612)
5. Cardoso EM, Stal P, Hagen K, Cabeda JM, Esin S, de Sousa M, et al. HFE mutations in patients with hereditary haemochromatosis in Sweden. J Internal Med 1998;243: 203-8. (Pubitemid 28238012)
6. McDonnell SM, Preston BL, Jewell SA, Barton JC, Edwards CQ, Adams PC, et al. A survey of 2851 patients with hemochromatosis: symptoms and response to treatment. Am J Med 1999;106:619-24. (Pubitemid 29279297)
7. Fargion S, Mandelli C, Piperno A, Cesana B, Francanzani AL, Fraquelli M, et al. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992;15: 655-9.
8. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110:1107-19. (Pubitemid 26113751)
9. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991;101:368-72.
10. Gurrin LC, Osborne NJ, Constantine CC, McLaren CE, English DR, Gertig DM, et al. The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis. Gastroenterology 2008;135: 1945-52.
11. Milman N, Pedersen P, Steig T, Byg KE, Graudal N, Fenger K. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 2001;80:737-44. (Pubitemid 34044096)
12. Wojcik JP, Speechley MR, Kertesz AE, Chakrabarti S, Adams PC. Natural history of C282Y homozygotes for hemochromatosis. Can J Gastroenterol 2002;16: 297-302. (Pubitemid 34846665)
13. Elmberg M, Hultcrantz R, Ekbom A, Brandt L, Olsson S, Olsson R, et al. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastro-enterology 2003;125:1733-41. (Pubitemid 37500438)
14. Elmberg M, Hultcrantz R, Ebrahim F, Olsson S, Lindgren S, Lööf L, et al. Increased mortality risk in patients with phenotypic hereditary hemochromatosis but not in their first-degree relatives. Gastroenterology 2009; 137:1301-9.
15. Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish GR. Hemochromatosis- associated mortality in the United States from 1979 to 1992: an analysis of Multiple-Cause Mortality Data. Ann Intern Med 1998;129:946-53. (Pubitemid 28549832)
16. Brown AS, Gwinn M, Cogswell ME, Khoury MJ. Hemochromatosis-associated morbidity in the United States: an analysis of the National Hospital Discharge Survey, 1979-1997. Genet Med 2001;3:109-11.
17. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G-> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002; 359:211-18. (Pubitemid 34113819)
18. McCune CA, Ravine D, Carter K, Jackson HA, Hutton D, Hedderich J, et al. Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients. Gut 2006;55: 554-62.
19. Buffone GJ, Beck JR. Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis. Clin Chem 1994;40:1631-6. (Pubitemid 24241164)
20. Stave GM, Mignogna JJ, Powell GS, Hunt CM. Evaluation of a workplace hemochromatosis screening program. Am J Prev Med 1999;16:303-6. (Pubitemid 29249376)
21. Delatycki MB, Allen KJ, Nisselle AE, Collins V, Metcalfe S, du Sart D, et al. Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis. Lancet 2005;366:314-16. (Pubitemid 41019421)
22. Powell LW, Dixon JL, Ramm GA, Purdie DM, Lincoln DJ, Anderson GJ, et al. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch Intern Med 2006;166:294-301. (Pubitemid 43244317)
23. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacter-iol 1962;84:53-64.
24. Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendler MH, Chaperon J, et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroen-terology 1998;115:929-36. (Pubitemid 28452941)
25. Beaton M, Guyader D, Deugnier Y, Moirand R, Chakrabarti S, Adams P. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 2002;36: 673-8. (Pubitemid 34977178)
26. Morrison ED, Brandhagen DJ, Phatak PD, Barton JC, Krawitt EL, El-Serag HB, et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 2003;15:138:627-33.
27. Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG. Hemochromatosis mutations in the general population: iron overload progression rate. Blood 2004;103:2914-19. (Pubitemid 38451659)
28. Gleeson F, Ryan E, Barrett S, Crowe J. Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening. Eur J Gastroenterol Hepatol 2004; 16:859-63. (Pubitemid 39179654)
29. Bulaj ZJ, Ajioka RS, Phillips JD, LaSalle BA, Jorde LB, Griffen LM, et al. Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 2000;343: 1529-35.
30. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms and age in 410 patients with genetic hemochromatosis. Hepatology 1997;25:162-66. (Pubitemid 27015004)
31. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008; 358:221-30.
32. Olsson KS, Ritter B, Rosen U, Heedman PA, Staugard F. Prevalence of iron overload in central Sweden. Acta Med Scand 1983;213:145-50. (Pubitemid 13144396)
33. Waalen J, Felitti VJ, Gelbart T, Beutler E. Screening for hemochromatosis by measuring ferritin levels: a more effective approach. Blood 2008;111:3373-6.